MTD Q3 Deep Dive: Industrial and Bioprocessing Drive Growth Amid Margin Pressures

Precision measurement company Mettler-Toledo (NYSE:MTD) reported Q3 CY2025 results topping the market’s revenue expectations , with sales up 7.9% year on year to $1.03 billion. On the other hand, next quarter’s revenue guidance of $1.08 billion was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $11.15 per share was 4.5% above analysts’ consensus estimates. Is now the time to buy MTD? Find out in our full research report (it’s free for active Edge members). Mettler-Tole ...